• Apply To Contribute To AlleyWatch
    • Write for AlleyWatch
  • Tell Us About Your Startup
  • Email Signup
  • Advertise on AlleyWatch
AlleyWatch
  • Business
  • Startups
  • Funding
  • Women in Tech
  • NYC Tech
No Result
View All Result
  • Business
  • Startups
  • Funding
  • Women in Tech
  • NYC Tech
No Result
View All Result
AlleyWatch
No Result
View All Result
Home AlleyTalk #NYCTech

NYC Startups Raised $5.69B in Q3 2026. It Took 40% Fewer Deals to Do It.

Reza Chowdhury by Reza Chowdhury
NYC Startups Raised $5.69B in Q3 2026. It Took 40% Fewer Deals to Do It.
Share on FacebookShare on Twitter

New York City startups raised $5.69 billion across 143 deals in Q3 2026 — 7% more capital than Q3 2025 on 40% fewer rounds, and the strongest third quarter since 2021. It was also the lightest of 2026’s first three quarters, 36% below Q2. Behind the headline: 16 mega-rounds took 61% of the money, September rebounded to $3.1 billion after the thinnest month of the year, and the median deal climbed to $13.0 million.

Total Raised
$5.69B
+7% vs Q3 2025
Total Deals
143
−40% vs Q3 2025
Median Deal
$13.0M
+58% vs Q3 2025
Avg Deal
$39.8M
+80% vs Q3 2025
Largest Round
$650M · Wonder
Mega Rounds ($100M+)
16 companies
Top 10 Concentration
49% of all capital
YTD Through Q3
$22.05B · 619 deals

Fewer Deals, Bigger Checks

New York’s venture ecosystem raised $5.69 billion across 143 rounds in July, August, and September — the best third quarter since 2021’s $9.63 billion and 7% above Q3 2025’s $5.31 billion. But the composition of that growth is the story. Deal count fell 40% year over year, from 240 to 143, the fewest rounds in any quarter in AlleyWatch’s index since at least 2021 (before late-reported rounds are added). Capital held up because the checks that did close were far larger: the median deal rose 58% to $13.0 million and the average rose 80% to $39.8 million.

Sixteen NYC startups raised $100 million or more, capturing 61% of all capital while representing 11% of deals. The top 10 companies alone took 49% of Q3 funding, up from 43% in Q2. Below the mega-round tier the market was quieter: 38 of 143 rounds, or 27%, were under $5 million, and only 14 landed between $50 million and $100 million.

Globally, the quarter was a step back from an extraordinary first half, but still historic. Crunchbase counts $159 billion of global venture funding in Q3, down 25% from Q2 and up 53% from a year earlier, with AI startups taking 64% of the total and a record 27 companies raising rounds of $1 billion or more. KPMG’s Venture Pulse puts global venture investment at $170.9 billion and US venture investment at $98.4 billion. New York’s 7% annual gain trailed the global 53%, and its 36% drop from Q2 was steeper than Crunchbase’s 25% global decline.

Capital YoY
+7%
Deal Count YoY
−40%
Median Deal YoY
+58%
Avg Deal YoY
+80%

Month by Month: How Q3 Unfolded

A quiet summer bracketed a strong September. August was the lightest month of 2026 on both capital and deal count; September then pulled the quarter back into respectable territory on ten rounds of $100 million or more.

July 2026
$1.8B
52 rounds · 5 at $100M+

A purposeful step down from June’s record. Capital fell 14% year over year and deal count 38% as the summer slowdown set in, but round sizes held. Wonder’s $650M Series D led the quarter, followed by CAIS ($170M), Gauntlet ($125M), Norm AI ($120M), and Cover Genius ($111M). Five rounds topped $100M, and just seven late-stage deals took $1.22B of the month’s capital. NYC captured 9.3% of US venture dollars.

August 2026
$806M
33 rounds · lightest month of 2026

The summer slowdown arrived on schedule. Capital fell 30% and deal count 44% from August 2025. Only one round cleared $100M — Cityblock Health’s $116M Series E — followed by Blank Street ($75M), RQD Clearing ($74M), and K Health ($58.9M). Late-stage companies took 71% of the capital on 11 deals, and AI-native companies appeared in at least 17 rounds. NYC took 4.8% of US venture dollars.

September 2026 · Rebound
$3.1B
58 rounds · 10 at $100M+

The rebound month. Capital rose 274% from August and finished 49% above September 2025, while US venture funding fell 5.8% over the same period. Ten rounds of $100M or more totaled $2.17B, 69% of the month’s capital: Cyera ($400M), EliseAI ($350M), Precision Neuroscience ($250M), David ($250M), General Intuition ($220M), Profound ($180M), Rightway ($155M), Forus ($150M), Clay ($115M), and Savvy Wealth ($100M). NYC took 10.8% of US venture dollars, up from 4.8% in August.

NYC in Global Context

New York’s Q3 sits inside a global market that cooled from Q2’s peak but remained far above any prior year. Crunchbase reports that 2026 funding through September totals $679 billion, the highest first-three-quarters total on record, and KPMG puts the nine-month global figure at $728.3 billion. The concentration is extreme: Crunchbase attributes roughly a third of Q3’s global dollars to the 27 companies that raised $1 billion or more, and PitchBook-NVCA reports that AI accounted for 82.7% of US deal value through September, the highest annual share in its dataset.

For New York, the national comparison turned on September. The city’s $3.14 billion was up 49% from a year earlier while US venture funding fell 5.8%, and its average September deal of $53.2M ran well above the $38.2M national average. Over the quarter, NYC’s share of US venture dollars swung from 9.3% in July to 4.8% in August to 10.8% in September — a reminder that a handful of rounds can move the city’s national share by several points in a single month.

Market Q3 2026 Capital Primary Driver
Global (Crunchbase) $159B AI 64% of funding; record 27 rounds of $1B+
Global (KPMG) $170.9B 8,341 deals; AI megadeals
United States (KPMG) $98.4B 3,626 deals; Databricks $5B, Crusoe $3.9B
North America (Crunchbase) $92B AI took $61B, roughly two-thirds
New York City ★ $5.69B AI, enterprise, health, food tech, fintech

AI Still Leads — But the Mix Shifted

AI companies raised $2.14 billion across 31 deals in Q3, 38% of all NYC capital. That is still the largest sector, but down from 51% in Q2. The quarter’s AI rounds ran from applied to research: Cyera raised $400M for AI-native data security, EliseAI $350M for AI automation in housing and healthcare, Profound $180M for AI visibility for brands, and Clay $115M for AI go-to-market. Two of Q2’s biggest names came back for more. General Intuition, the world-model research lab that raised $320M in June, closed another $220M on September 29 — $540M within four months. Cyera went from $300M in June to $400M in September.

The rotation underneath was sharper than the headline. Finance fell to $815.6M across 25 deals, 14% of capital, from $2.51B and 28% in Q2 — Ramp’s $750M Series F alone was nearly as large as Q3’s entire finance total. FoodTech surged to $1.01B on just five deals, anchored by Wonder ($650M), David ($250M), and Blank Street ($75M), tying HealthTech at $1.01B across 14 deals. Health-focused rounds included Precision Neuroscience ($250M), Rightway ($155M), Forus ($150M), and Cityblock Health ($116M). Sector categories overlap, so shares sum to more than 100%.

NYC Startup Funding by Sector — Q3 2026 · Source: AlleyWatch

Sector Raised Deals Q3 Share Q2 Share
AI $2.14B 31 38% 51%
Enterprise $1.31B 38 23% 46%
HealthTech $1.01B 14 18% 12%
FoodTech $1.01B 5 18% —
Data & Analytics $819.5M 11 14% 10%
Finance $815.6M 25 14% 28%

Stage-by-Stage: Where the Money Went

Late-stage deals — 22% of transactions — captured 70% of capital at a $75.0M median, essentially the same concentration as Q2’s 69%, but on a smaller base: 31 late-stage rounds against 41 in Q2, at an average of $128.8M versus $148.3M. The mega-round engine kept running; it simply had fewer pistons.

The thinning was most visible in the middle of the market. Series A fell to 44 deals from 82 in Q2, at a $10.1M median (Q2: $12.3M). Series B slipped to 16 deals from 29, though its median rose to $35.0M from $21.6M — fewer companies, larger rounds. Early-stage activity, 52 deals at a $3.5M median, made up 36% of all transactions, down from 81 deals in Q2.

Q3 2026 NYC Tech Funding by Stage · Source: AlleyWatch

Stage Deals % Deals Total % Cap Avg Deal Median
Late Stage 31 22% $3.99B 70% $128.8M $75.0M
Series A 44 31% $562.2M 10% $12.8M $10.1M
Series B 16 11% $809.3M 14% $50.6M $35.0M
Early Stage 52 36% $320.5M 6% $6.2M $3.5M

“New York took 10.8% of US venture capital in September, up from 4.8% in August, as national funding fell 5.8% from a year ago.”

AlleyWatch · September 2026 NYC Venture Capital Funding Report

Exit Market: Liquidity Arrives at the Top

Exits, not new deals, defined the third quarter nationally. PitchBook’s Q3 Venture Monitor summary describes realizations approaching record highs globally while dealmaking moved sideways and fundraising kept sliding, and NVCA reports that 18 companies went public in the US during the quarter.

In New York, AlleyWatch’s index recorded 37 acquisitions and mergers of NYC startups in Q3 and one IPO, Yarrow (YARW). The marquee transaction was NVIDIA’s agreement to acquire Hugging Face for $12.9 billion, announced September 3 and expected to close in the first half of 2027. Vitruvian Partners also took a majority stake in Smartling from Battery Ventures on September 15, on undisclosed terms.

Company Acquired By Value
Hugging Face NVIDIA $12.9B announced
Smartling Vitruvian Partners Undisclosed (majority stake)
Oasis Security Cyera $190M raised

The 25 Largest NYC Venture Capital Deals of Q3 2026

Source: AlleyWatch · funding.alleywatch.com

# Company Amount Stage Date
1 Wonder $650.0M Series D Jul 16
2 Cyera $400.0M Series G Sep 22
3 EliseAI $350.0M Venture Sep 29
4 David $250.0M Series B Sep 2
5 Precision Neuroscience $250.0M Series D Sep 25
6 General Intuition $220.0M Venture Sep 29
7 Profound $180.0M Series D Sep 15
8 CAIS $170.0M Series D Jul 30
9 Rightway $155.0M Series E Sep 24
10 Forus $150.0M Series C Sep 8
11 Gauntlet $125.0M Series C Jul 13
12 Norm AI $120.0M Series C Jul 7
13 Cityblock Health $116.0M Series E Aug 24
14 Clay $115.0M Series D Sep 9
15 Cover Genius $111.0M Venture Jul 14
16 Savvy Wealth $100.0M Series C Sep 9
17 Sequen $90.0M Series B Sep 10
18 Blank Street $75.0M Series C Aug 25
19 RQD Clearing $74.0M Venture Aug 31
20 Inspiren $70.0M Series C Sep 10
21 Fora $60.0M Series D Jul 16
22 InstaLILY AI $60.0M Series B Jul 15
23 K Health $58.9M Venture Aug 19
24 Ultra.tech $57.1M Venture Aug 20
25 Confido $55.0M Series B Sep 22

Most Active NYC Investors — Q3 2026

Y Combinator led all investors with 9 deals, followed by Alumni Ventures and Insight Partners at 7 and BoxGroup at 6. Andreessen Horowitz, General Catalyst, Khosla Ventures, and Thrive Capital each logged 5, and Bessemer Venture Partners and Abstract each logged 4. Insight’s count reflects growth-stage activity across Fora, InstaLILY AI, Inspiren, and Confido, while BoxGroup slipped from the top spot it held in Q2 with 9 deals.

# Investor Deals
1 Y Combinator 9
2 Alumni Ventures 7
3 Insight Partners 7
4 BoxGroup 6
5 Andreessen Horowitz 5
6 General Catalyst 5
7 Khosla Ventures 5
8 Thrive Capital 5
9 Bessemer Venture Partners 4
10 Abstract 4

Macro Headwinds: What Could Slow the Momentum

The data behind Q3 points to a market that is healthy at the top and thinning underneath. Four pressures are worth watching into year-end.

Concentration. PitchBook-NVCA reports AI at 82.7% of US deal value through September, and KPMG describes funding flowing to a small number of large AI deals with a more selective environment for everyone else. In New York, the top 10 companies took 49% of Q3 capital.

A squeezed fundraising base. US venture funds raised $108.5 billion through Q3, but funds of $500 million or more took 78.1% of it, and managers raising a fourth fund or later captured 88.2%. Only 81 first-time funds have closed, on pace for the fewest in a decade. That is a quiet headwind for the seed and early-stage managers that supply much of New York’s deal count.

A thinning middle. NYC deal count fell 40% year over year, Series A volume nearly halved from Q2, and September’s 58 rounds compared with 95 a year earlier. Capital is available; the number of companies reaching it is shrinking.

Macro and geopolitical noise. KPMG cites geopolitical uncertainty as a backdrop to Q3 and flags a possible slowdown tied to the US midterm elections in Q4, while J.P. Morgan’s Q3 commentary names interest-rate expectations as an increasingly important factor for equity markets and the AI narrative.

NYC’s Structural Strengths

Against that backdrop, New York’s advantages showed up in who wrote the checks. Cyera’s $400M round was backed by Goldman Sachs Growth Equity. EliseAI drew Ontario Teachers’ Pension Plan alongside Bessemer and Andreessen Horowitz. Precision Neuroscience’s $250M round brought in ARK Investment Management, Pershing Square Inc., Duquesne Family Office, and Mubadala Capital. Norm AI’s $120M round included Blackstone, Vanguard, and TIAA. The city’s proximity to institutional capital is a durable edge in a market where late-stage rounds are getting larger and the investors writing them are increasingly crossover and institutional.

The same density supports the application layer. Finance, health, real estate, and enterprise customers sit within a subway ride of the founders building AI for them. And the exit side is no longer theoretical: a $12.9 billion acquisition of Hugging Face and a majority investment in Smartling both landed in September.

Historical Context and Q4 Outlook

Through the first nine months of 2026, NYC startups raised $22.05 billion across 619 deals. As of November 19, the year-to-date total stands at $27.89 billion across 701 deals — already 46% above 2025’s full-year $19.1 billion and the second-most-funded year in AlleyWatch’s index, behind only the 2021 peak of $35.1 billion.

NYC Q3 Funding by Year · Source: AlleyWatch

Q3 of Capital Deals Median Character
2026 $5.69B 143 $13.0M Mega-round era; fewest deals since at least 2021
2025 $5.31B 240 $8.3M AI recovery builds
2024 $3.36B 198 $7.4M Stabilization
2023 $2.35B 182 $4.7M Trough
2022 $3.96B 248 $7.0M Boom-to-correction
2021 $9.63B 273 $9.5M Zero-rate boom peak

Q3 is historically NYC venture’s quietest period, and 2026 followed the pattern: the quarter was the lightest of the year’s first three. The recovery has already begun. Q4 is at $5.84 billion across 82 deals through November 19 — already ahead of Q3 with six weeks left — on the strength of Ramp’s $1.85 billion round, Kalshi’s $1.0 billion, and Modal’s $750 million, all closed in October.

New York raised $5.69 billion in what is historically its quietest quarter. Capital is not the constraint. Rounds are. The winners of the NYC AI era are still being selected, and Q3 showed how few companies the selection process now reaches.


Methodology & Sources. NYC quarterly and monthly funding figures sourced from the AlleyWatch NYC Funding Index (funding.alleywatch.com), updated daily. Q3 2026 covers July ($1.8B, 52 rounds), August ($806M, 33 rounds), and September ($3.1B, 58 rounds). Stage, sector, round size, largest rounds, investor, and exit data from the AlleyWatch Q3 2026 Quarterly Report. Monthly commentary draws on the AlleyWatch July, August, and September 2026 New York Venture Capital Funding Reports; figures in those reports were published before late-reported rounds were added and may differ slightly. Q2 2026 comparisons use current index values ($8.84B, 231 deals), which differ slightly from the Q2 report as originally published. Year-over-year comparisons use Q3 2025 values of $5.31B and 240 deals. Global and national context from Crunchbase News Q3 2026 global funding report (October 2026); KPMG Venture Pulse Q3’26 (October 14, 2026); PitchBook-NVCA Venture Monitor Q3 2026; and J.P. Morgan Commercial Banking Q3 2026 Trends in Venture Capital. NVIDIA’s Hugging Face acquisition per NVIDIA’s September 3, 2026 announcement; Smartling per the September 15, 2026 Vitruvian Partners and Smartling announcement. All figures in USD. NYC defined as the five boroughs per AlleyWatch methodology. Data subject to revision as late-reported rounds are added.

Tags: AbstractAlumni VenturesAndreessen HorowitzARK Investment ManagementBattery VenturesBessemer Venture PartnersBlackstoneBlank StreetBoxGroupCAISCityblock HealthClayConfidoCover GeniusCyeraDavidDuquesne Family OfficeEliseAIForaForusGauntletGeneral CatalystGeneral IntuitionGoldman Sachs Growth EquityHugging FaceInsight PartnersInspirenInstaLILY AIK HealthKalshiKhosla VenturesModalMubadala CapitalNorm AINvidiaOasis SecurityOntario Teachers' Pension PlanPershing Square Inc.Precision NeuroscienceProfoundRampRightwayRQD ClearingSavvy WealthSequenSmartlingThrive CapitalTIAAUltra.techVanguardVitruvian PartnersWonderY CombinatorYarrow
Previous Post

These 8 NYC Agentic Startups Launched out of Stealth at Betaworks Camp Demo Day

ABOUT ALLEYWATCH

ABOUT US
ADVERTISE
EDITORIAL GUIDELINES
LEGAL
PRIVACY
TERMS OF USE

CONTACT

CONTACT US
ADVERTISE
TIPS
WRITE FOR US
EMAIL SIGNUP

CHANNELS

NYC VC
NYC TECH EVENTS
NYC TECH NEWS
NYC STARTUPS
NYC COWORKING
TECH DIRECTORY

© 2023 AlleyWatch | All Rights Reserved | Proudly Made for NYC

No Result
View All Result
  • Home
  • Startups
  • Funding
  • AlleyTalk

© 2023 AlleyWatch | All Rights Reserved | Proudly Made for NYC

You are seconds away from signing up for the hottest list in New York Tech!

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Close this popup